Literature DB >> 15206654

Polypoidal choroidal vasculopathy associated with Doyne's familial choroiditis: treatment with thermal laser.

I D Ladas1, D A Karagiannis, I Georgalas, A A Rouvas, M M Moschos, M Apostolopoulos.   

Abstract

PURPOSE: To report the unusual occurrence of polypoidal choroidal vasculopathy (PCV) in a patient with Doyne's familial honeycomb choroiditis (DFHC) and its course after laser treatment.
DESIGN: Interventional case report.
METHODS: Indocyanine green (ICG) angiography guided laser was performed on active polypoidal lesions.
RESULTS: A 45-year-old man with a 15-year history of bilateral DFCH and a scarred macular choroidal neovascularization in the right eye (RE) was referred to us with exudative maculopathy in the left eye (LE). His best-corrected visual acuity (BCVA) was 20/800 in the RE and 20/40 in the LE. ICG angiography revealed a picture that was characteristic for PCV in both eyes. ICG guided argon green laser was performed on the active parapapillary and perifoveal polypoidal lesions of the LE. Eight months after the laser photocoagulation treatment, the macular exudative lesions had subsided and the BCVA improved to 20/20. The favorable anatomic and functional results have remained stable over 3 years.
CONCLUSIONS: This is, to our knowledge, the first case of a PCV that occurred secondary to DFHC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206654

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  2 in total

1.  Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients.

Authors:  Giridhar Anantharaman; Gudapati Ramkumar; Mahesh Gopalakrishnan; Alpesh Rajput
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

2.  Combined cases of polypoidal choroidal vasculopathy and typical age-related macular degeneration.

Authors:  Ichiro Maruko; Tomohiro Iida; Masaaki Saito; Dai Nagayama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.